JOHNSON & JOHNSON revenue for the last year amounted to 330.07 T COP, the most of which — 212.24 T COP — came from its highest performing source at the moment, Innovative Medicine, the year earlier bringing 255.16 T COP. The greatest contribution to the revenue figure was made by United States — last year it brought JOHNSON & JOHNSON 180.02 T COP, and the year before that — 235.83 T COP.